Literature DB >> 32569450

Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective.

Zeeshan Mansuri1, Bhumika Shah, Mahwish Adnan, Gaurav Chaudhari, Taranjeet Jolly.   

Abstract

Entities:  

Year:  2020        PMID： 32569450     DOI： 10.4088/PCC.20com02677

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  4 in total

1.  Chronic Pediatric Pain and Mental Illness During the COVID-19 Era: A Case Series From Inpatient Child Psychiatry Unit.

Authors:  Ankit Jain; Sage Gee; Srikrishna V Malayala; Christopher W Laboe
Journal:  Cureus       Date:  2021-11-30

2.  Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.

Authors:  Beatriz Oda Plasencia-García; Gonzalo Rodríguez-Menéndez; María Isabel Rico-Rangel; Ana Rubio-García; Jaime Torelló-Iserte; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

3.  Psychotropics and COVID-19: An analysis of safety and prophylaxis.

Authors:  H Javelot; C Straczek; G Meyer; C Gitahy Falcao Faria; L Weiner; D Drapier; E Fakra; P Fossati; S Weibel; S Dizet; B Langrée; M Masson; R Gaillard; M Leboyer; P M Llorca; C Hingray; E Haffen; A Yrondi
Journal:  Encephale       Date:  2021-09-02       Impact factor: 1.291

4.  A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals.

Authors:  Yugendar R Alugubelli; Zhi Zachary Geng; Kai S Yang; Namir Shaabani; Kaustav Khatua; Xinyu R Ma; Erol C Vatansever; Chia-Chuan Cho; Yuying Ma; Jing Xiao; Lauren R Blankenship; Ge Yu; Banumathi Sankaran; Pingwei Li; Robert Allen; Henry Ji; Shiqing Xu; Wenshe Ray Liu
Journal:  Eur J Med Chem       Date:  2022-07-08       Impact factor: 7.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.